4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0000921895-25-001730
Options or other derivatives
- Director acquired 6,682 shares (grant or award)
From the SEC's structured data for this filing
MoonLake Immunotherapeutics Filed Acc 0000921895-25-001730
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…